Produced:
2019
Client:
MaxCyte
Category:
Other
![Kundens logga](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb5517d_63eb9d64ec1db2b08ad594ca_logo-260x40.webp)
Description
The promising field of cell therapy relies on the researchers' ability to carefully engineer a patient's cells using complex combinations of nucleic acids and proteins. As a therapy progresses from concept to clinic, the volume of engineered cells required for successful passage increases dramatically. Therapeutic development is often a race against time, but for many transfection technologies, scaling up can be problematic, causing significant increases in timelines, costs and risks.
![](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb5517d_63eb9d64ec1db2b08ad594ca_logo-260x40.webp)
![](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb55189_63ef8740bab7d83dd0eedb6c_MaxCyte%2520-%2520Cellular%2520Therapy2.jpeg)
![](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb55186_63ef87418cede9b701b195d6_MaxCyte%2520-%2520Cellular%2520Therapy3.jpeg)
![](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb5519d_63ef8740db6602f185299a0d_MaxCyte%2520-%2520Cellular%2520Therapy4.jpeg)
![](https://assets-global.website-files.com/63e0f575707c28091f857dd1/647458a1b2c76397ccb5518f_63ef87406fd458126b31728c_MaxCyte%2520-%2520Cellular%2520Therapy5.jpeg)
No items found.